SLE Clinical Trials

982 recruitingLast updated: June 20, 2026

There are 982 actively recruiting sle clinical trials across 74 countries. Studies span Not Applicable, Phase 2, Phase 1, Phase 4, Phase 3, Early Phase 1. Top locations include Boston, Massachusetts, United States, New York, New York, United States, Beijing, Beijing Municipality, China. Updated daily from ClinicalTrials.gov.


SLE Trials at a Glance

982 actively recruiting trials for sle are listed on ClinicalTrialsFinder across 6 cities in 74 countries. The largest study group is Not Applicable with 490 trials, with the heaviest enrollment activity in Boston, New York, and Beijing. Lead sponsors running sle studies include VA Office of Research and Development, Chinese University of Hong Kong, and University of Pittsburgh.

Treatments under study

About SLE Clinical Trials

Looking for clinical trials for SLE? There are currently 11 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new SLE trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about SLE clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 982 trials

Recruiting
Not Applicable

Multidimensional Sleep Health Intervention to Optimize Concussion Recovery

TreatmentDepression, AnxietySleep Health+2 more
University of Colorado, Denver54 enrolled1 locationNCT07082218
Recruiting

Studying Childhood-onset Behavioral, Psychiatric, and Developmental Disorders

SleepNeurodevelopmental DisorderNeurological Disorder+1 more
National Institute of Mental Health (NIMH)1,000 enrolled1 locationNCT01778504
Recruiting
Not Applicable

Innovative OSA Screening in Head and Neck Cancer Patients With the Apneal App

Head and Neck CancersObstructive Sleep Apnea Hypopnea Syndrome (OSAHS)
University Hospital, Caen20 enrolled1 locationNCT06896448
Recruiting

Development of a Wearable Point of Care Monitoring Device for Pediatric Obstructive Sleep Apnea

Pediatric Obstructive Sleep Apnea
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)120 enrolled1 locationNCT05052216
Recruiting
Phase 2

Intestinal Low-Dose Radiotherapy Plus Immunochemotherapy for Conversion of Borderline Resectable/Unresectable Esophageal Squamous Cell Carcinoma

ChemotherapyRadiotherapyImmune Checkpoint Inhibitor+4 more
Chuangzhen Chen43 enrolled1 locationNCT07339488
Recruiting

Gonadotropin-releasing Hormone Agonist (GnRHa) in Ovarian Preservation in SLE Subjects Receiving Cyclophosphamide as Determined by Questionnaires

Systemic Lupus Erythematosus (SLE)Primary Ovarian Insufficiency (Poi)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)100 enrolled1 locationNCT05567198
Recruiting
Not Applicable

A Dyadic Sleep Health Approach for Persons With Alzheimer's Disease and Caregivers

Sleep
University of California, Los Angeles672 enrolled3 locationsNCT05452031
Recruiting
Not Applicable

Myofunctional Therapy for Obstructive Sleep Apnea

Obstructive Sleep Apnea
University of Minnesota30 enrolled1 locationNCT07301125
Recruiting
Phase 2

Targeting Cognition in Early Alzheimer's Disease by Improving Sleep With Trazodone

Sleep DisturbanceAMCI - Amnestic Mild Cognitive Impairment
Johns Hopkins University100 enrolled1 locationNCT05282550
Recruiting
Not Applicable

Bruxism Therapy of Facial Pain

Sleep QualityBruxismBruxism, Sleep-Related
Fondazione Policlinico Universitario Agostino Gemelli IRCCS42 enrolled1 locationNCT07611643
Recruiting
Not Applicable

Treatment Failure of Continuous Positive Airway Pressure (CPAP) in Patients With Obstructive Sleep Apnea Syndrome (OSA): A Trial Comparing Polysomnography and the Sunrise Device to Drive Treatment-Adjustment Decisions.

Sleep Apnea Syndrome, Obstructive
University Hospital, Grenoble105 enrolled1 locationNCT07530302
Recruiting
Not Applicable

Weighted Blanket Use for Adults With Chronic Pain

Musculoskeletal PainSleep DisturbanceChronic Pain+1 more
National University of Natural Medicine44 enrolled1 locationNCT07498491
Recruiting
Not Applicable

Start CPAP Therapy in Obstructive Sleep Apnea Patients After Atrial Fibrillation Ablation

Sleep-disordered breathing (SDB)Obstructive Sleep ApneaArrhythmia+3 more
Beijing Anzhen Hospital658 enrolled27 locationsNCT07444372
Recruiting
Phase 2

Sleep Trial to Prevent Alzheimer's Disease

SleepAlzheimer Disease
Washington University School of Medicine200 enrolled1 locationNCT04629547
Recruiting
Not Applicable

Atrial Fibrosis in Obstructive Sleep Apnea Patients: A Pilot Study

Atrial FibrillationObstructive Sleep Apnea
Tulane University60 enrolled3 locationsNCT04814420
Recruiting
Phase 1Phase 2

CD19-Directed Chimeric Antigen Receptor Autologous T Cells (CART19) for Lupus

CAR-T CellSLESystemic Lupus Erythematosus (SLE)+4 more
Children's Hospital of Philadelphia24 enrolled1 locationNCT06839976
Recruiting
Phase 1

A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease

SLE (Systemic Lupus)Diffuse Cutaneous Systemic SclerosisSystemic Sclerosis+4 more
CRISPR Therapeutics80 enrolled14 locationsNCT06925542
Recruiting
Phase 2

Tislelizumab Combined With Anlotinib and Nab-paclitaxel in III Resectable Non-small Cell Lung Cancer : A Prospective, Single-Arm, Phase II Study

NSCLCTislelizumabNab-paclitaxel+1 more
Qilu Hospital of Shandong University34 enrolled1 locationNCT07089199
Recruiting
Not Applicable

The Effect of a Daily Magnesium and Melatonin Supplement on Sleep Quality in People With Nighttime Leg Cramps

Leg Cramps, NocturnalPoor sleep quality
StudySetGo50 enrolled1 locationNCT07651514
Recruiting

A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants

Systemic Lupus Erythematosus (SLE)
Bristol-Myers Squibb223 enrolled64 locationsNCT07175285